Research output per year
Research output per year
Fingerprint
Dive into the research topics where Gaia Piperno is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Borghetti, P., Imbrescia, J., Volpi, G., Scotti, V., Aquilano, M., Bruni, A., Franceschini, D., Ursino, S., Ciammella, P., Piperno, G., Taraborrelli, M. & Magrini, S. M., Dec 2022, In: Radiation Oncology. 17, 1, 124.Research output: Contribution to journal › Article › peer-review
Open Access -
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era: Critical Reviews in Oncology/Hematology
Catania, C., Piperno, G., Russo, A., Greco, C., Agustoni, F., Scotti, V., Proto, C., Sangalli, C., Patani, F., Santacaterina, A., Di Pietro Paolo, M., Agresti, B., Filippi, A. R. & Ramella, S., 2022, In: Crit. Rev. Oncol. Hematol.. 174Research output: Contribution to journal › Article › peer-review
-
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era
Catania, C., Piperno, G., Russo, A., Greco, C., Agustoni, F., Scotti, V., Proto, C., Sangalli, C., Patani, F., Santacaterina, A., Di Pietro Paolo, M., Agresti, B., Filippi, A. R. & Ramella, S., Jun 2022, In: Critical Reviews in Oncology/Hematology. 174, 103684.Research output: Contribution to journal › Review article › peer-review
-
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the ‘radio talk’ webinars
Borghetti, P., Guerini, A. E., Sangalli, C., Piperno, G., Franceschini, D., La Mattina, S., Arcangeli, S. & Filippi, A. R., 2022, (Accepted/In press) In: Expert Review of Anticancer Therapy.Research output: Contribution to journal › Review article › peer-review
-
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Bruni, A., Scotti, V., Borghetti, P., Vagge, S., Cozzi, S., D’Angelo, E., Giaj Levra, N., Fozza, A., Taraborrelli, M., Piperno, G., Vanoni, V., Sepulcri, M., Trovò, M., Nardone, V., Lattanzi, E., Bou Selman, S., Bertolini, F., Franceschini, D., Agustoni, F., Jereczek-Fossa, B. A., & 4 others, Sep 28 2021, In: Front. Oncol.. 11, p. 1-7 7 p., 744956.Research output: Contribution to journal › Article › peer-review